E89R
TEAS SECTION 8 & 9 RECEIVED
08/14/2026
Back to search
Official data from USPTO
PAR MED PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
08/14/2026
Trademark type
Combined
Nice classes
35
Filing date
02/26/2016
Registration date
10/11/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/28/2022
Last transaction
08/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
12/01/2015
First use in commerce
12/01/2015
Drawing code
3
Owner type
16
Owner location
Dublin, OH, US
Examiner
DUONG, SUI
Law office
M70
Current location
TMO LAW OFFICE 116
Mark description
The mark consists of the word "PAR MED PHARMACEUTICALS" presented on two lines of text in which a knot design appears between the letters "PAR" and "MED". A line separates the wording "PAR MED" and "PHARMACEUTICALS".
Holders and representatives
Holders
Cardinal Health 110, LLC
Representatives
N. Christopher Norton ArentFox Schiff LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
distributorship services in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
20 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/11/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/28/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/28/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/28/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/21/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2016
PUBO
PUBLISHED FOR OPPOSITION
07/26/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/17/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/17/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/17/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/17/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/17/2016
DOCK
ASSIGNED TO EXAMINER
06/10/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2016
NWAP
NEW APPLICATION ENTERED
03/01/2016
Continuous trademark protection
Get notified about every new filing that threatens PAR MED PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.